| For: | Chen H, Shen Y, Wu SD, Zhu Q, Weng CZ, Zhang J, Wang MX, Jiang W. Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis. World J Gastroenterol 2023; 29(39): 5503-5525 [PMID: 37900994 DOI: 10.3748/wjg.v29.i39.5503] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v29/i39/5503.htm |
| Number | Citing Articles |
| 1 |
Ellina Lytvyak, Gideon Hirschfield, Devika Shreekumar, Yu Jun Wong, Aldo J. Montano‐Loza. Pathogenesis, Non‐Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases. Liver International 2025; 45(8) doi: 10.1111/liv.70190
|
| 2 |
Haiping Zhang, Jianping Ren, Xinming Li, Yinxue Ma, Lijuan Li, Chen Shao, Kechi Fang, Jie Lu, Huiping Yan, Yanmin Liu, Jing Wang. A machine learning model incorporating the globulin-to-platelet index for predicting severe fibrosis in autoimmune hepatitis: A retrospective and prospective validation study. Medicine 2026; 105(19) doi: 10.1097/MD.0000000000048408
|
| 3 |
Tancredi V. LI CAVOLI, Armando CURTO, Erica N. LYNCH, Andrea GALLI, Stefano MILANI. Disease-specific non-invasive assessment of liver fibrosis and portal hypertension. Minerva Gastroenterology 2025; 71(3) doi: 10.23736/S2724-5985.25.03845-8
|
| 4 |
Martine A.M.C. Baven-Pronk, Camiel J.M. Marijnissen, Maaike Biewenga, Albert F. Stättermayer, Maarten E. Tushuizen, Bart van Hoek. Aspartate aminotransferase‑to‑platelet ratio index (APRI) reliably excludes advanced fibrosis and cirrhosis in treated autoimmune hepatitis. Annals of Hepatology 2026; 31(1) doi: 10.1016/j.aohep.2025.102146
|
| 5 |
Zixian Wang, Qiying Yu, Yanan Sun, Yanlou Liang, Shanshan Chen, Shuhui Xie, Jing Wu. A nomogram model integrating ultrasound-based multimodal radiomics features and clinical indexes for diagnosing significant hepatic fibrosis in AILD patients. Abdominal Radiology 2025; doi: 10.1007/s00261-025-05342-8
|
| 6 |
Palida Palahati, Maimaitiaili Tuerxun, Aziguli Abulaiti, Mireayi Tudi, Mayire Tuersun, Aikepaer Aiken. Clinical characteristics and factors associated with liver stiffness in patients with autoimmune liver disease: a cross-sectional study from the Kashgar region. BMC Gastroenterology 2025; 26(1) doi: 10.1186/s12876-025-04577-5
|
| 7 |
Ellina Lytvyak, Devika Shreekumar, Yu Jun Wong and
Aldo J. Montano-Loza. Updates in Autoimmune Diseases [Working Title]. 2026; doi: 10.5772/intechopen.1013551
|
| 8 |
В.Н. Наджафова. NON-INVASIVE RADIODIAGNOSIS OF HEPATIC FIBROSIS IN DIABETIC PATIENTS. Azerbaijan Medical Journal 2024; (2) doi: 10.34921/amj.2024.80.94.002
|
| 9 |
Wenpeng Huang, Yushuo Peng, Lei Kang. Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future. VIEW 2024; 5(4) doi: 10.1002/VIW.20240010
|
| 10 |
Jihyun An, Young Eun Chon, Gunho Kim, Mi Na Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Miyoung Choi, Dae Won Jun, Seung Up Kim, Ji Won Han, Young-Joo Jin. Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis. Clinical and Molecular Hepatology 2024; 30(Suppl) doi: 10.3350/cmh.2024.0586
|
| 11 |
Riccardo Righetti, Felice Cinque, Keyur Patel, Giada Sebastiani. The role of noninvasive biomarkers for monitoring cell injury in advanced liver fibrosis. Expert Review of Gastroenterology & Hepatology 2025; 19(1) doi: 10.1080/17474124.2025.2450717
|
| 12 |
Marcial Sebode, Heike Bantel, Ulrich Baumann, Philip Bufler, Münevver Demir, Leona Dold, Verena Keitel-Anselmino, Reinhild Klein, Andreas E. Kremer, Petra L. Jansen, Michael Melter, Peter Schirmacher, Christoph Schramm, Martina Sterneck, Christian P. Strassburg, Christina Weiler-Normann, Ansgar W. Lohse. Update der S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Living guideline. Zeitschrift für Gastroenterologie 2026; 64(05) doi: 10.1055/a-2769-2475
|
| 13 |
Nobuyuki Toshikuni. Letter: Reassessing Liver Biopsy Deferral in Antinuclear Antibody‐Positive Patients: The Clinical Necessity of Objective Fibrosis Staging. Alimentary Pharmacology & Therapeutics 2026; doi: 10.1111/apt.70722
|
| 14 |
Xinyi Men, Yansheng Liu, Han Zhao, Bingrui Xie, Changcun Guo, Patrick S. C. Leung, Suraj Timilsina, M. Eric Gershwin, Yulong Shang, Ying Han. The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine. Clinical Reviews in Allergy & Immunology 2025; 68(1) doi: 10.1007/s12016-025-09074-x
|
| 15 |
Sajid Jalil, Mangesh Pagadala, Nicholas Dunn, Hanna Blaney, Mohamed Elfeki, Nimish Thakral, Ashwani K. Singal. Transient Elastography and Fibroscan: Stethoscope of a Hepatologist in Today’s World. Current Hepatology Reports 2025; 24(1) doi: 10.1007/s11901-025-00713-7
|
| 16 |
Emrah Karatay, Abdulkadir Eren, Fateme Azizi, Emre Karacay. Comparison of Liver Lobes Shear-Wave Elastography Values with Histopathological Classifications in Autoimmune Hepatitis Cases. Hepatitis Monthly 2026; 26(1) doi: 10.5812/hepatmon-168384
|
| 17 |
David Mehdi Asgher Niazi, Conrad Rauber. Letter: Reassessing Liver Biopsy Deferral in Antinuclear Antibody‐Positive Patients: The Clinical Necessity of Objective Fibrosis Staging. Authors' Reply. Alimentary Pharmacology & Therapeutics 2026; doi: 10.1111/apt.70748
|
| 18 |
Alexei Goncharov, Vasily Isakov. Dual cut-offs and beyond: Expanding the role of transient elastography in primary biliary cholangitis. World Journal of Gastroenterology 2026; 32(8): 115416 doi: 10.3748/wjg.v32.i8.115416
|